Dantrolene Exerts Protective Activity in Double and Triple Combination with Nimodipine, Ruthenium Red and Basilene Blue in Bilirubin-Induced Neurotoxicity in Cell Culture of Rats

REFERENCES

• Bakuridze K., Düzenli S., Gepdiremen A. The role of ruthenium red as a partial agonist in caffeine-induced neurotoxicity in cerebellar granular cell culture of rats. International Journal of Neuroscience 2005; 115: 13–21
   PubMed Web of Science ®Google Scholar
• Berridge M. J. Capacitative calcium entry. Biochemical Journal 1995; , 312: 1–11
   PubMed Web of Science ®Google Scholar
• Brito M. A., Brites D., Butterfield D. A. A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Research 2004; 5: 33–43
   Google Scholar
• Buss W. C., Savage D. D., Stepanek J., Little S. A., McGuffee L. J. Effect of calcium channel antagonists on calcium uptake and release by isolated rat cardiac mitochondria. European Journal of Pharmacology 1998; 152: 247–253
   Google Scholar
• Cavaliere F., D’Ambrossi N., Ciotti M. T., Mancino G., Sancesario G., Bernardi G., et al. Glucose deprivation and chemical hypoxia: Neuroprotection by P2 receptor antagonists. Neurochemistry International 2001; 38: 189–197
   PubMedGoogle Scholar
• Chan C. F., Lin-Shiau S. Y. Site of action of suramin and reactive blue 2 in preventing neuronal death induced by dequalinium. Journal of Neuroscience Research 2000; 62: 692–699
   PubMedGoogle Scholar
• Chang J. Y., Korolev V. V. Spesific toxicity of tunicamycin in induction of programmed cell death in sympathetic neurons. Experimental Neurology 1996; 137: 201–211
   PubMedGoogle Scholar
• Churn S. B., DeLorenzo R. J., Shapiro S. M. Bilirubin induces a calcium-dependent inhibition of multifunctional Ca2+/calmodulin-dependent kinase II activity in vitro. Pediatric Research 1995; 38: 949–954
   PubMedGoogle Scholar
• Clapham D. E. Calcium signalling. Cell 1995; 80: 259–268
   PubMed Web of Science ®Google Scholar
• Dennery P. A., Seidman D. S., Stevenson D. K. Neonatal hyperbilirubinemia. New England Journal of Medicine 2001; 344: 581–590
   PubMed Web of Science ®Google Scholar
• Gepdiremen A., Düzenli S., Hacimuftuoglu A., Süleyman H., Oztas S. The effects of dantrolene alone or in combination with nimodipine in glutamate-induced neurotoxicity in cerebellar granular cell cultures of rat pups. Pharmacological Research 2001; 43: 241–244
   PubMed Web of Science ®Google Scholar
• Gepdiremen A., Sönmez S., Batat I., Esrefoglu M., Düzenli S., Süleyman H. Nimodipine improves kainic acid induced neurotoxicity in cerebellar granular cell culture: A double blind dose-response study. Fundamental and Clinical Pharmacology 1997; 11: 117–120
   PubMedGoogle Scholar
• Hansen T. W. Fetal and neonatal bilirubin metabolism. Neonatal Jaundice, M. J. Maisels, J. F. Watchko. Harwood Academic Publishers, Amsterdam 2000
   Google Scholar
• Hansen T. W., Mathiesen S. B., Walaas S. I. Bilirubin has widespread inhibitory effects on protein phosphorylation. Pediatric Research 1996; 39: 1072–1077
   PubMed Web of Science ®Google Scholar
• Henschke P. N., Elliot S. J. Oxidize glutathione decreases luminal Ca2+ content of endothelial cells in (1,4,5) P3-sensitive Ca2+ store. Biochemical Journal 1995; 312: 485–489
   PubMedGoogle Scholar
• Kaya M., Tunc M., Ozdemir T., Altuntas I. Calcium antagonists in N-methyl d-aspartate-induced retinal injury. Graefes Archive for Clinical and Experimental Ophthalmology 2003; 241: 418–422
   PubMed Web of Science ®Google Scholar
• Ohno T. Kernikterus: Effect on choline acetyl transferase, glutamic acid decarboxylase and tyrosine hydroxylase activities in the brain of the Gunn rat. Brain Research 1980; 196: 282–285
   PubMedGoogle Scholar
• Ostrow D. J., Pascolo L., Tribelli C. Mechanisms of bilirubin neurotoxicity. Hepatology 2002; 35: 1277–1280
   PubMed Web of Science ®Google Scholar
• Rodrigues C. M., Sola S., Silva R., Brites D. Bilirubin and amyloid beta peptide induce cytochrome-c release through mitochondrial membrane permeabilization. Molecular Medicine 2000; 6: 936–946
   PubMed Web of Science ®Google Scholar
• Rodrigues C. M., Sola S., Silva R. F., Brites D. Aging confers different sensitivity to the neurotoxic properties of unconjugated bilirubin. Pediatric Research 2002; 51: 112–118
   PubMed Web of Science ®Google Scholar
• Schiff D., Chan G., Poznansky M. J. Bilirubin toxicity in neural cell lines N-115 and NBR-10A. Pediatric Research 1985; 19: 908–911
   PubMed Web of Science ®Google Scholar
• Shaia W. T., Shapiro S. M., Heller A. J., Galiani D. L., Sismanis A., Spencer R. F. Immunohistochemical localization of calcium-binding proteins in the brainstem vestibular nuclei of the jaundiced Gunn rat. Hearing Research 2002; 173: 82–90
   PubMedGoogle Scholar
• Silva R., Mata L. R., Gulbenkian S., Brito M. A., Tribelli C., Brites D. Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytes: Role of concentration and pH. Biochemical and Biophysical Research Communications 1999; 265: 67–72
   PubMedGoogle Scholar
• Silva R. F. M., Rodrigues C. M. P., Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. Journal of Hepatology 2001; 34: 402–408
   PubMed Web of Science ®Google Scholar
• Tirosh O., Sen C. K., Roy S., Packer L. Cellular and mitochondrial changes in glutamate-induced HT4 neuronal cell death. Neurosciences 2000; 97: 531–541
   PubMedGoogle Scholar
• Velasco I., Tapia R. Alterations of intracellular calcium homeostasis and mitochondrial function are involved in Ruthenium Red neurotoxicity in primary cortical cultures. Journal of Neuroscience 2000; 60: 543–551
   Google Scholar
• Watchko J. F., Dood M. J., Hansen T. W. Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatric Research 1998; 44: 763–766
   PubMed Web of Science ®Google Scholar
• Xu J., Wojcik W. J. Gamma aminobutyric acid B receptor mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: Blockade by islet activating protein. Journal of Pharmacology and Experimental Therapeutic 1986; 239: 568–573
   PubMedGoogle Scholar
• Zhou X. F., Zhang L., Tseng E., Scott-Ramsay E., Schentag J. J., Coburn R. A., et al. New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as p-glycoprotein inhibitors. Drug Metabolism and Disposition 2005; 33: 321–328
   PubMed Web of Science ®Google Scholar